CompletedNot applicableNCT00273390

A Clinical Trial of Infliximab for Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oregon Health and Science University
Principal Investigator
James T Rosenbaum, MD
Oregon Health and Science University
Intervention
Remicade (infliximab)(drug)
Enrollment
32 target
Eligibility
9 years · All sexes
Timeline
20012006

Collaborators

Centocor, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00273390 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials